Skip to main content
Clinical Trials/JPRN-UMIN000043407
JPRN-UMIN000043407Completed未知

Effects of peptide ingestion on sleep: a randomized, double-blind, placebo-controlled, parallel-group study - Effects of peptide ingestion on sleep

everage Brain Inc.0 sites70 target enrollmentStarted: February 24, 2021Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
70

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
30years-old to 65years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1) Subjects who are undergoing medical treatment or diagnosed as needing medical treatment 2) Subjects who are pregnant, lactation, or planning to become pregnant during this study 3) Subjects who have history of serious disorders (Cerebrovascular disease, Cardiac disorder, Hepatic disorders, Gastrointestinal disorder, Endocrine-related disorder, etc.) 4) Subjects who have or have a history of sleep disorders such as insomnia or sleep apnea syndrome (SAS) 5) Subjects with medication allergies, food allergies, or a serious history of such allergies 6) Subjects who have or have a history of drug addiction or alcoholism 7) Subjects who are judged by the principal investigator to have an irregular lifestyle 8) Subjects who regularly use medicines, supplements, etc. 9) Subjects who urinate more than 3 times during the night 10) Extremely heavy drinkers (more than 60g/day of alcohol) 11) Subjects who have participated in other drug or food trials within the past month, or are willing to participate during this study 12) Subjects who are judged as ineligible to participate in this study by the principal investigator

Investigators

Sponsor
everage Brain Inc.

Similar Trials